Contineum Therapeutics, Inc. (CTNM)

NASDAQ: CTNM · Real-Time Price · USD

4.450

+0.800 (21.92%)

Jun 20, 2025, 1:25 PM - Market open

Contineum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 20, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	115	378	-	-	-
Enterprise Value	-82	164	-	-	-
Last Close Price	3.65	14.65	-	-	-
Debt / Equity Ratio	0.03	0.03	0.01	0.15	0.08
Debt / EBITDA Ratio	-	-	0.03	-	-
Debt / FCF Ratio	-	-	0.03	-	-
Asset Turnover	-	-	0.55	-	-
Quick Ratio	21.31	20.53	22.83	6.26	18.78
Current Ratio	21.47	20.69	23.29	6.41	18.99
Return on Equity (ROE)	-33.03%	-26.19%	27.71%	-48.09%	-
Return on Assets (ROA)	-22.95%	-18.54%	11.10%	-23.44%	-
Return on Capital (ROIC)	-23.95%	-19.30%	11.79%	-25.44%	-
Return on Capital Employed (ROCE)	-	-	12.90%	-	-
Buyback Yield / Dilution	-981.89%	-469.95%	-51.38%	-6.35%	-

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q